Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Biol Chem. 2010 Oct 1;285(40):30443-52. doi: 10.1074/jbc.M110.143792. Epub 2010 Jul 27.
Here, we demonstrate that p68 (DDX5) and p72 (DDX17), two homologous RNA helicases and transcriptional cofactors, are substrates for the acetyltransferase p300 in vitro and in vivo. Mutation of acetylation sites affected the binding of p68/p72 to histone deacetylases, but not to p300 or estrogen receptor. Acetylation additionally increased the stability of p68 and p72 RNA helicase and stimulated their ability to coactivate the estrogen receptor, thereby potentially contributing to its aberrant activation in breast tumors. Also, acetylation of p72, but not of p68 RNA helicase, enhanced p53-dependent activation of the MDM2 promoter, pointing at another mechanism of how p72 acetylation may facilitate carcinogenesis by boosting the negative p53-MDM2 feedback loop. Furthermore, blocking p72 acetylation caused cell cycle arrest and apoptosis, revealing an essential role for p72 acetylation. In conclusion, our report has identified for the first time that acetylation modulates RNA helicases and provides multiple mechanisms how acetylation of p68 and p72 may affect normal and tumor cells.
在这里,我们证明了 p68(DDX5)和 p72(DDX17)这两种同源 RNA 解旋酶和转录共因子是乙酰转移酶 p300 的体外和体内的底物。乙酰化位点的突变影响了 p68/p72 与组蛋白去乙酰化酶的结合,但不影响 p300 或雌激素受体。乙酰化还增加了 p68 和 p72 RNA 解旋酶的稳定性,并刺激了它们激活雌激素受体的能力,从而可能导致其在乳腺癌中的异常激活。此外,p72 RNA 解旋酶的乙酰化而不是 p68 的乙酰化增强了 p53 依赖性的 MDM2 启动子的激活,指出了 p72 乙酰化如何通过增强负反馈环 p53-MDM2 促进致癌作用的另一种机制。此外,阻断 p72 乙酰化导致细胞周期停滞和细胞凋亡,揭示了 p72 乙酰化的重要作用。总之,我们的报告首次确定了乙酰化调节 RNA 解旋酶,并提供了 p68 和 p72 乙酰化影响正常和肿瘤细胞的多种机制。